Shining on Major News: Pacific Biosciences (NASDAQ:PACB), Northern Oil and Gas (NYSEMKT:NOG), American Airlines (NASDAQ:AAL), American Water Works (NYSE:AWK), IntelliPharmaCeutics International (NASDAQ:IPCI)

Pacific Biosciences of California, Inc. (NASDAQ:PACB) belongs to Healthcare sector. Its weekly performance is 1.86%. On last trading day company shares ended up $5.47. Pacific Biosciences of California, Inc. (NASDAQ:PACB) distance from 50-day simple moving average (SMA50) is -3.18%. Pacific Biosciences of California, Inc. (NASDAQ:PACB) said that, it will hold its quarterly conference call to discuss its Second Quarter 2015 Financial Results on Wednesday, August 5, 2015, at 4:30pm Eastern Time.

Northern Oil and Gas, Inc. (NYSEMKT:NOG) belongs to Basic Materials sector. Its net profit margin is -12.30% and weekly performance is 3.56%. On last trading day company shares ended up $5.82. Northern Oil and Gas, Inc. (NYSEMKT:NOG) distance from 50-day simple moving average (SMA50) is -17.10%. National Securities began coverage on shares Northern Oil and Gas, Inc. (NYSEMKT:NOG) in a report released on Thursday. The firm issued a buy rating and a $7.00 price objective on the energy company’s stock.

American Airlines Group Inc. (NASDAQ:AAL) shares moved up 2.94% in last trading session and ended the day at $42.42. AAL Gross Margin is 31.30% and its return on assets is 7.40%. American Airlines Group Inc. (NASDAQ:AAL) quarterly performance is -11.05%. American Airlines Group Inc. (NASDAQ:AAL) said that, it set Oct. 17 as the date for the complex task of migrating merger partner US Airways onto the American Airlines reservation system.

On 13 July, American Water Works Company, Inc. (NYSE:AWK) shares moved up 0.39% and was closed at $50.99. AWK EPS growth in last 5 year was 30.80%. American Water Works Company, Inc. (NYSE:AWK) year to date (YTD) performance is -3.18%. On 9 July, American Water Works Company, Inc. (NYSE:AWK) announced that it has completed its acquisition of Keystone Clearwater Solutions (Keystone).

IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) shares increased 2.30% in last trading session and ended the day at $3.56. IPCI return on assets is -53.40%. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) quarterly performance is 23.18%. IntelliPharmaCeutics International Inc. (NASDAQ:IPCI) reported that, Revenue related to the Company’s license and commercialization agreement with Par Pharmaceutical, Inc. (“Par”) in the three months ended May 31, 2015 was $1.2 million versus $1.4 million in the three months ended May 31, 2014.

Leave a Reply

Your email address will not be published. Required fields are marked *